亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢勵合化學新材料有限公司  

埃索美拉唑,奧美拉唑硫醚,埃索美拉唑鈉,埃索美拉唑鎂三水合物,5-甲氧基-2-巰基-1H-苯并咪唑,阿瑞匹坦,頭孢雷特,普拉格雷,烏苯美司,硫酸胍乙啶,利伐沙班,依澤替米貝,福辛普利鈉,頭孢替安酯

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張文
  • 電話:027-88391805
  • 郵件:whlhhx@sina.com
  • 傳真:027-88391805
  • QQ:1053653497
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 供應雷美替胺中間體196597-78-1
供應雷美替胺中間體196597-78-1
單價 23500.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 1000kg起訂1kg
品牌 武漢勵合
型號 196597-78-1
規格 196597-78-1
含量 99%
過期 長期有效
更新 2014-12-11 14:46
 
詳細信息
1,2,6,7-四氫-8H-茚并[5,4-b]呋喃-8-酮196597-78-1(雷美替胺中間體)  
英文名稱:1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one
中文名稱:1,2,6,7-四氫-8H-茚并[5,4-b]呋喃-8-酮
MF:C11H10O2
MW:174.2
CAS:196597-78-1
含量:99%
性狀:類白色至淡黃色固體
售價:23500/kg
聯系人:張文
手機號碼:13871015067     
聯系電話:027-88391805
傳真:027-88391805
QQ:1053653497
©2025 武漢勵合化學新材料有限公司 版權所有   技術支持:化工網   訪問量:5326  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |